{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:38:42Z","timestamp":1773664722324,"version":"3.50.1"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2012,6,22]],"date-time":"2012-06-22T00:00:00Z","timestamp":1340323200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0038867","type":"journal-article","created":{"date-parts":[[2012,6,22]],"date-time":"2012-06-22T23:34:49Z","timestamp":1340408089000},"page":"e38867","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Mitochondrionopathy Phenotype in Doxorubicin-Treated Wistar Rats Depends on Treatment Protocol and Is Cardiac-Specific"],"prefix":"10.1371","volume":"7","author":[{"given":"Gon\u00e7alo C.","family":"Pereira","sequence":"first","affiliation":[]},{"given":"Susana P.","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Claudia V.","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 A.","family":"Lumini","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9","family":"Magalh\u00e3es","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio","family":"Ascens\u00e3o","sequence":"additional","affiliation":[]},{"given":"Maria S.","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio J.","family":"Moreno","sequence":"additional","affiliation":[]},{"given":"Paulo J.","family":"Oliveira","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2012,6,22]]},"reference":[{"key":"ref1","first-page":"670","article-title":"The anthracyclines: will we ever find a better doxorubicin?","volume":"19","author":"RB Weiss","year":"1992","journal-title":"Semin Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.2174\/138161211796904812","article-title":"Drug-induced cardiac mitochondrial toxicity and protection: from doxorubicin to carvedilol.","volume":"17","author":"GC Pereira","year":"2011","journal-title":"Curr Pharm Des"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","article-title":"Risk factors for doxorubicin-induced congestive heart failure.","volume":"91","author":"DD Von Hoff","year":"1979","journal-title":"Ann Intern Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1001\/jama.1991.03470120074036","article-title":"Cardiac toxicity 4 to 20 years after completing anthracycline therapy.","volume":"266","author":"LJ Steinherz","year":"1991","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1034\/j.1600-0773.2003.930301.x","article-title":"Doxorubicin-induced cardiac mitochondrionopathy.","volume":"93","author":"KB Wallace","year":"2003","journal-title":"Pharmacol Toxicol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1134\/S000629790602012X","article-title":"Doxorubicin-induced thiol-dependent alteration of cardiac mitochondrial permeability transition and respiration.","volume":"71","author":"PJ Oliveira","year":"2006","journal-title":"Biochemistry (Mosc)"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.freeradbiomed.2008.08.008","article-title":"Doxorubicin increases the susceptibility of brain mitochondria to Ca(2+)-induced permeability transition and oxidative damage.","volume":"45","author":"S Cardoso","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s12012-007-0026-0","article-title":"Persistent alterations to the gene expression profile of the heart subsequent to chronic Doxorubicin treatment.","volume":"7","author":"JM Berthiaume","year":"2007","journal-title":"Cardiovasc Toxicol"},{"key":"ref9","first-page":"771","article-title":"Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin.","volume":"61","author":"S Zhou","year":"2001","journal-title":"Cancer Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-2999(01)00782-8","article-title":"Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat.","volume":"414","author":"G Sacco","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/CIRCULATIONAHA.109.902221","article-title":"Juvenile exposure to anthracyclines impairs cardiac progenitor cell function and vascularization resulting in greater susceptibility to stress-induced myocardial injury in adult mice.","volume":"121","author":"C Huang","year":"2010","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.bmc.2004.10.066","article-title":"Cardioprotective activity of melatonin and its novel synthesized derivatives on doxorubicin-induced cardiotoxicity.","volume":"13","author":"HH Ahmed","year":"2005","journal-title":"Bioorg Med Chem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"H722","DOI":"10.1152\/ajpheart.01249.2004","article-title":"Moderate endurance training prevents doxorubicin-induced in vivo mitochondriopathy and reduces the development of cardiac apoptosis.","volume":"289","author":"A Ascens\u00e3o","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1023\/A:1008352620870","article-title":"Effect of single chemotherapeutic agents on the growing skeleton of the rat.","volume":"11","author":"BL van Leeuwen","year":"2000","journal-title":"Ann Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.taap.2004.04.005","article-title":"Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity.","volume":"200","author":"PJ Oliveira","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.pcad.2006.10.002","article-title":"Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management.","volume":"49","author":"G Takemura","year":"2007","journal-title":"Prog Cardiovasc Dis"},{"key":"ref17","first-page":"17","article-title":"Echocardiographic Evaluation in Experimental Pathology.","volume":"1","author":"C Br\u00e1s","year":"2007","journal-title":"Exp Pathol Health Sci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bcp.2009.08.010","article-title":"Adenosine A3 receptor-mediated cardioprotection against doxorubicin-induced mitochondrial damage.","volume":"79","author":"AK Emanuelov","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/abbi.1999.1624","article-title":"Carvedilol inhibits the exogenous NADH dehydrogenase in rat heart mitochondria.","volume":"374","author":"PJ Oliveira","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.tiv.2009.06.032","article-title":"Toxicity assessment of the herbicide metolachlor comparative effects on bacterial and mitochondrial model systems.","volume":"23","author":"SP Pereira","year":"2009","journal-title":"Toxicol In Vitro"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/dmrr.423","article-title":"Calcium-dependent mitochondrial permeability transition is augmented in the kidney of Goto-Kakizaki diabetic rat.","volume":"20","author":"PJ Oliveira","year":"2004","journal-title":"Diabetes Metab Res Rev"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0021-9258(18)57021-6","article-title":"Determination of serum proteins by means of the biuret reaction.","volume":"177","author":"AC Gornal","year":"1949","journal-title":"J Biol Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF01868720","article-title":"Membrane potential of mitochondria measured with an electrode sensitive to tetraphenyl phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state.","volume":"49","author":"N Kamo","year":"1979","journal-title":"J Membr Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0076-6879(96)69007-7","article-title":"Measuring nitric oxide and superoxide: rate constants for aconitase reactivity.","volume":"269","author":"A Hausladen","year":"1996","journal-title":"Methods Enzymol"},{"key":"ref25","article-title":"Biostatistical analysis: Prentice Hall.","author":"JH Zar","year":"1999"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1385\/CT:5:3:257","article-title":"Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunction.","volume":"5","author":"JM Berthiaume","year":"2005","journal-title":"Cardiovasc Toxicol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.taap.2004.04.005","article-title":"Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity.","volume":"200","author":"PJ Oliveira","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.2174\/092986709788803312","article-title":"Doxorubicin: the good, the bad and the ugly effect.","volume":"16","author":"C Carvalho","year":"2009","journal-title":"Curr Med Chem"},{"key":"ref29","first-page":"39","article-title":"Pharmacological strategies to counteract doxorubicin-induced cardiotoxicity : the role of mitochondria.","volume":"1","author":"GC Pereira","year":"2008","journal-title":"J Theor Exp Pharm"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity.","volume":"56","author":"G Minotti","year":"2004","journal-title":"Pharmacol Rev"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10565-008-9070-1","article-title":"Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets.","volume":"25","author":"VA Sardao","year":"2009","journal-title":"Cell Biol Toxicol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10517-005-0138-0","article-title":"Morphological manifestations of heart remodeling in anthracycline-induced dilated cardiomyopathy.","volume":"138","author":"EL Lushnikova","year":"2004","journal-title":"Bull Exp Biol Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ultrasmedbio.2007.07.018","article-title":"Early detection of doxorubicin cardiomyopathy using two-dimensional strain echocardiography.","volume":"34","author":"RQ Migrino","year":"2008","journal-title":"Ultrasound Med Biol"},{"key":"ref34","first-page":"8","article-title":"Chemotherapy Induced Cardiomyopathy: Pathogenesis, Monitoring and Management.","volume":"1","author":"D Shakir","year":"2009","journal-title":"J Clin Med Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1006\/jmcc.1996.0095","article-title":"Dose-dependent increase in sensitivity to calcium-induced mitochondrial dysfunction and cardiomyocyte cell injury by doxorubicin.","volume":"28","author":"LE Solem","year":"1996","journal-title":"J Mol Cell Cardiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.tox.2005.12.009","article-title":"Depletion of adenine nucleotide translocator protein in heart mitochondria from doxorubicin-treated rats\u2013relevance for mitochondrial dysfunction.","volume":"220","author":"PJ Oliveira","year":"2006","journal-title":"Toxicology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/eurheartj\/ehl013","article-title":"Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury.","volume":"27","author":"TG Neilan","year":"2006","journal-title":"Eur Heart J"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/pbc.20016","article-title":"Exercise echocardiography reflects cumulative anthracycline exposure during childhood.","volume":"42","author":"E Smibert","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.yjmcc.2006.06.009","article-title":"New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics.","volume":"41","author":"M Tokarska-Schlattner","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"ref40","first-page":"460","article-title":"Effect of anthracycline antibiotics on oxygen radical formation in rat heart.","volume":"43","author":"JH Doroshow","year":"1983","journal-title":"Cancer Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00258216","article-title":"Tissue distribution of doxorubicin and doxorubicinol in rats receiving multiple doses of doxorubicin.","volume":"7","author":"JH Peters","year":"1981","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1042\/CS20100254","article-title":"Acute exercise protects against calcium-induced cardiac mitochondrial permeability transition pore opening in doxorubicin-treated rats.","volume":"120","author":"A Ascensao","year":"2011","journal-title":"Clin Sci (Lond)"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1158\/0008-5472.CAN-08-3076","article-title":"Pretreatment with statin attenuates the cardiotoxicity of Doxorubicin in mice.","volume":"69","author":"A Riad","year":"2009","journal-title":"Cancer Res"},{"key":"ref44","first-page":"505","article-title":"Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity.","volume":"11","author":"P Bai","year":"2004","journal-title":"Oncol Rep"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3945\/jn.109.113415","article-title":"Oral glutamine protects against acute doxorubicin-induced cardiotoxicity of tumor-bearing rats.","volume":"140","author":"VK Todorova","year":"2010","journal-title":"J Nutr"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0006-8993(00)02255-1","article-title":"Genetic variability in morphine sensitivity and tolerance between different strains of rats.","volume":"866","author":"M Mas","year":"2000","journal-title":"Brain Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/009841096161960","article-title":"Role of rat strain in the differential sensitivity to pharmaceutical agents and naturally occurring substances.","volume":"47","author":"S Kacew","year":"1996","journal-title":"J Toxicol Environ Health A"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0005-2728(97)00055-8","article-title":"Preferential oxidation of cardiac mitochondrial DNA following acute intoxication with doxorubicin.","volume":"1321","author":"CMM Palmeira","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12012-007-0024-2","article-title":"Genotyping the risk of anthracycline-induced cardiotoxicity.","volume":"7","author":"S Deng","year":"2007","journal-title":"Cardiovasc Toxicol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.critrevonc.2005.01.005","article-title":"Predicting drug response and toxicity based on gene polymorphisms.","volume":"54","author":"J Robert","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1634\/theoncologist.4-1-45","article-title":"Long-term survivors of childhood cancer: the late effects of therapy.","volume":"4","author":"CL Schwartz","year":"1999","journal-title":"Oncologist"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0097795","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T00:00:00Z","timestamp":1399593600000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0038867","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T10:41:05Z","timestamp":1642588865000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0038867"}},"subtitle":[],"editor":[{"given":"Valdur","family":"Saks","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2012,6,22]]},"references-count":51,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,6,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0038867","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,22]]}}}